How did Fiasp stay under the radar so long?

Can anyone find the Phase I results?

Can anyone find a PK profile?

Does anyone know how the delivery method differs from the approach BIOD was taking? IE, are there site tolerability issues with this drug as well?

This jumped completely out of the blue - I was sleeping well at night knowing that there were no viable competitors in the Ultra-Rapid Acting field - this now has me worried.